Señales en vivo de SYRE | Maximiza tus Ganancias con Getagraph.com

COMPRAR 136712 min ago

@ $22.52

Emitido: 14 feb 2024 @ 15:56

Retorno: 67.85%

Señal anterior: feb 14 - 09:38

Señal anterior: Vender

Retorno: -2.04 %

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Stats
Volumen de hoy	308 277
Volumen promedio	479 925
Capitalización de mercado	1.52B
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $-0.900 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0610 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-14	Fairmount Funds Management Llc	Buy	11 323	Stock Option (Right to Buy)
2024-05-14	Milligan Sandra	Buy	21 980	Stock Option (Right to Buy)
2024-05-14	Albers Jeffrey W.	Buy	11 323	Stock Option (Right to Buy)
2024-05-14	Stelzer Laurie	Buy	11 323	Stock Option (Right to Buy)
2024-05-14	Henderson Michael Thomas	Buy	11 323	Stock Option (Right to Buy)

INSIDER POWER
13.64
Last 16 transactions
Buy: 4 580 807 \| Sell: 4 003 472

Volumen Correlación

Largo: 0.16 (neutral)

Corto: 0.47 (neutral)

Signal:(46.203) Neutral

Spyre Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spyre Therapeutics, Inc. Correlación - Moneda/Commodity

-0.54
( weak negative )

-0.23
( neutral )

0.00
( neutral )

-0.59
( weak negative )

-0.23
( neutral )

0.76
( moderate )

Spyre Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$886 000
Beneficio Bruto:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

FY	2023
Ingresos:	$886 000
Beneficio Bruto:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

Financial Reports:

No articles found.

Spyre Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.